• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C群脑膜炎球菌疫苗接种运动时代的菌株变化:1997 - 2012年比利时的趋势与演变

Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012.

作者信息

Mattheus Wesley, Hanquet Germaine, Collard Jean-Marc, Vanhoof Raymond, Bertrand Sophie

机构信息

Sections of Bacterial Diseases, Scientific Institute of Public Health, Brussels, Belgium.

Medical Epidemiologist, Health Care Knowledge Centre, Brussels, Belgium.

出版信息

PLoS One. 2015 Oct 1;10(10):e0139615. doi: 10.1371/journal.pone.0139615. eCollection 2015.

DOI:10.1371/journal.pone.0139615
PMID:26425857
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4591272/
Abstract

BACKGROUND

Invasive meningococcal disease (IMD) is a major cause of bacterial meningitides and septicaemia. This study shows the results of the laboratory-based surveillance of IMD in Belgium over the period 1997-2012.

METHODS

The results are based on microbiological and molecular laboratory surveillance of 2997 clinical isolates of N. meningitides received by the Belgian Meningococcal Reference Centre (BMRC) over the period 1997-2012.

RESULTS

Serogroup B has always been a major cause of meningococcal disease in Belgium, with P3.4 as most frequent serotype till 2008, while an increase in non-serotypable strains has been observed in the last few years. Clonal complexes cc-41/44 and cc-269 are most frequently observed in serogroup B strains. In the late nineties, the incidence of serogroup C disease increased considerably and peaked in 2001, mainly associated with phenotypes C:2a:P1.5,2, C:2a:P1.5 and C:2a:P1.2 (ST-11/ET-37 clonal complex). The introduction of the meningococcal C conjugate vaccine has been followed by an 88% significant decrease in serogroup C disease from 2001 to 2004 nationally, yet sharper in Flanders (92%) compared to Wallonia (77%). Since 2008 a difference in incidence of serogroup C was observed in Flanders (0-0.1/100,000) versus Wallonia (0.1-0.3/100,000).

CONCLUSION

This study showed the change in epidemiology and strain population over a 16 years period spanning an exhaustive vaccination campaign and highlights the influence of regional vaccination policies with different cohorts sizes on short and long-term IMD incidences.

摘要

背景

侵袭性脑膜炎球菌病(IMD)是细菌性脑膜炎和败血症的主要病因。本研究展示了1997年至2012年期间比利时基于实验室的IMD监测结果。

方法

研究结果基于1997年至2012年期间比利时脑膜炎球菌参考中心(BMRC)接收的2997株脑膜炎奈瑟菌临床分离株的微生物学和分子实验室监测。

结果

B群一直是比利时脑膜炎球菌病的主要病因,直到2008年P3.4是最常见的血清型,而在过去几年中观察到不可分型菌株有所增加。克隆复合体cc-41/44和cc-269在B群菌株中最常被观察到。在九十年代后期,C群疾病的发病率大幅上升,并在2001年达到峰值,主要与C:2a:P1.5,2、C:2a:P1.5和C:2a:P1.2表型(ST-11/ET-37克隆复合体)相关。自2001年至2004年全国范围内引入脑膜炎球菌C结合疫苗后,C群疾病显著下降了88%,但在弗拉芒地区(92%)比瓦隆地区(77%)下降得更明显。自2008年以来,弗拉芒地区(0-0.1/100,000)和瓦隆地区(0.1-0.3/100,000)的C群发病率出现差异。

结论

本研究显示了在长达16年的全面疫苗接种运动期间流行病学和菌株群体的变化,并突出了不同队列规模的区域疫苗接种政策对短期和长期IMD发病率的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff49/4591272/6bb40b17f84f/pone.0139615.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff49/4591272/9a4c5f1c9204/pone.0139615.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff49/4591272/d8ef86feb98a/pone.0139615.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff49/4591272/6bb40b17f84f/pone.0139615.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff49/4591272/9a4c5f1c9204/pone.0139615.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff49/4591272/d8ef86feb98a/pone.0139615.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff49/4591272/6bb40b17f84f/pone.0139615.g003.jpg

相似文献

1
Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012.C群脑膜炎球菌疫苗接种运动时代的菌株变化:1997 - 2012年比利时的趋势与演变
PLoS One. 2015 Oct 1;10(10):e0139615. doi: 10.1371/journal.pone.0139615. eCollection 2015.
2
Serogroup C meningococci in Italy in the era of conjugate menC vaccination.结合型C群脑膜炎球菌疫苗时代的意大利C群脑膜炎球菌
BMC Infect Dis. 2009 Aug 22;9:135. doi: 10.1186/1471-2334-9-135.
3
Molecular surveillance of brazilian meningococcal isolates serogroup c in the pre and post-men-c-vaccination period: Emergence of ST-3780.分子监测巴西脑膜炎奈瑟菌 C 群在脑膜炎球菌疫苗接种前后的流行情况:ST-3780 的出现。
Infect Genet Evol. 2020 Mar;78:104079. doi: 10.1016/j.meegid.2019.104079. Epub 2019 Nov 14.
4
Epidemiological and Molecular Characterization of Invasive Meningococcal Disease in Italy, 2008/09-2012/13.2008/09 - 2012/13年意大利侵袭性脑膜炎球菌病的流行病学和分子特征
PLoS One. 2015 Oct 7;10(10):e0139376. doi: 10.1371/journal.pone.0139376. eCollection 2015.
5
A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.脑膜炎球菌 C 群结合疫苗引入后十年的群体保护。
Clin Infect Dis. 2014 Nov 1;59(9):1216-21. doi: 10.1093/cid/ciu601. Epub 2014 Jul 28.
6
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Isolated from 2009 to 2013 in the Republic of Ireland.爱尔兰共和国 2009 至 2013 年分离的侵袭性 B 群血清型 4CMenB 疫苗的潜在覆盖范围。
mSphere. 2018 Aug 22;3(4):e00196-18. doi: 10.1128/mSphere.00196-18.
7
Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.2000 - 2013年安大略省C群和Y群侵袭性脑膜炎球菌病(IMD)的流行病学:疫苗计划影响评估
Vaccine. 2015 Oct 13;33(42):5678-5683. doi: 10.1016/j.vaccine.2015.08.023. Epub 2015 Aug 20.
8
Genome-based study of a spatio-temporal cluster of invasive meningococcal disease due to Neisseria meningitidis serogroup C, clonal complex 11.基于基因组的研究显示,由于脑膜炎奈瑟菌 C 群、克隆复合体 11 导致了时空聚集性侵袭性脑膜炎球菌病。
J Infect. 2016 Aug;73(2):136-44. doi: 10.1016/j.jinf.2016.05.003. Epub 2016 May 24.
9
Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.1999 年 6 月至 2011 年 6 月期间荷兰侵袭性脑膜炎奈瑟菌病的疾病负担:血清群和克隆复合物的主观作用。
Clin Infect Dis. 2015 Oct 15;61(8):1281-92. doi: 10.1093/cid/civ506. Epub 2015 Jun 29.
10
[Epidemiology of the meningococcal disease in Catalonia before and after vaccination against serogroup C].[加泰罗尼亚地区接种C群脑膜炎球菌疫苗前后的脑膜炎球菌病流行病学情况]
Rev Esp Salud Publica. 2009 Sep-Oct;83(5):725-35. doi: 10.1590/s1135-57272009000500013.

引用本文的文献

1
Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs.对单价脑膜炎奈瑟菌 C 结合疫苗在常规免疫规划中的影响和效果的系统文献回顾。
BMC Public Health. 2020 Dec 9;20(1):1890. doi: 10.1186/s12889-020-09946-1.
2
Diversity of meningococci associated with invasive meningococcal disease in the Republic of Ireland over a 19 year period, 1996-2015.1996-2015 年期间爱尔兰共和国侵袭性脑膜炎奈瑟菌病相关脑膜炎奈瑟菌的多样性。
PLoS One. 2020 Feb 13;15(2):e0228629. doi: 10.1371/journal.pone.0228629. eCollection 2020.

本文引用的文献

1
A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.脑膜炎球菌 C 群结合疫苗引入后十年的群体保护。
Clin Infect Dis. 2014 Nov 1;59(9):1216-21. doi: 10.1093/cid/ciu601. Epub 2014 Jul 28.
2
Detection of a geographical and endemic cluster of hyper-invasive meningococcal strains.检测到具有地理和地方性的高侵袭性脑膜炎奈瑟菌菌株集群。
Microbes Infect. 2011 Jul;13(7):684-90. doi: 10.1016/j.micinf.2011.02.006. Epub 2011 Mar 2.
3
Vaccine development against Neisseria meningitidis.针对脑膜炎奈瑟菌的疫苗研发。
Microb Biotechnol. 2011 Jan;4(1):20-31. doi: 10.1111/j.1751-7915.2010.00178.x.
4
Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity.英格兰和威尔士对C群脑膜炎球菌结合疫苗的上市后监测更新:有效性、保护血清学关联验证以及群体免疫持续时间的模型预测
Clin Vaccine Immunol. 2010 May;17(5):840-7. doi: 10.1128/CVI.00529-09. Epub 2010 Mar 10.
5
The epidemiology of meningococcal disease and the impact of vaccines.脑膜炎奈瑟菌病的流行病学和疫苗的影响。
Expert Rev Vaccines. 2010 Mar;9(3):285-98. doi: 10.1586/erv.10.3.
6
Influence of two vaccination campaigns on genetic diversity of invasive Neisseria meningitidis isolates in northern Spain (1997-2008).在西班牙北部(1997-2008 年),两次疫苗接种运动对侵袭性脑膜炎奈瑟菌分离株遗传多样性的影响。
PLoS One. 2009 Dec 30;4(12):e8501. doi: 10.1371/journal.pone.0008501.
7
Global epidemiology of meningococcal disease.脑膜炎球菌病的全球流行病学
Vaccine. 2009 Jun 24;27 Suppl 2:B51-63. doi: 10.1016/j.vaccine.2009.04.063. Epub 2009 May 27.
8
Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002-2006.2002 - 2006年葡萄牙脑膜炎奈瑟菌荚膜转换的分子监测
Epidemiol Infect. 2009 Feb;137(2):161-5. doi: 10.1017/S0950268808001106. Epub 2008 Jul 31.
9
Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.脑膜炎球菌C群结合疫苗对带菌状态和群体免疫的影响。
J Infect Dis. 2008 Mar 1;197(5):737-43. doi: 10.1086/527401.
10
Molecular typing of meningococci: recommendations for target choice and nomenclature.脑膜炎球菌的分子分型:靶点选择和命名的建议
FEMS Microbiol Rev. 2007 Jan;31(1):89-96. doi: 10.1111/j.1574-6976.2006.00057.x. Epub 2006 Dec 1.